GAIL ECKHARDT to Angiogenesis Inhibitors
This is a "connection" page, showing publications GAIL ECKHARDT has written about Angiogenesis Inhibitors.
Connection Strength
0.059
-
Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models. Anticancer Drugs. 2018 10; 29(9):827-838.
Score: 0.034
-
Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model. Int J Cancer. 2015 Apr 15; 136(8):1967-75.
Score: 0.026